Ginkgo Bioworks Holdings (DNA) Finished Goods (2020 - 2023)
Ginkgo Bioworks Holdings (DNA) posted Finished Goods of $4.4 million for Q2 2023, down 16.26% on a QoQ basis from $5.3 million in Q1 2023, and down 41.06% year-over-year from $7.5 million in Q2 2022.
Ginkgo Bioworks Holdings (DNA) Finished Goods (2020 - 2023) Analysis & Trends
Ginkgo Bioworks Holdings' Finished Goods history runs 4 years deep, the most recent figure standing at $4.4 million for Q2 2023.
- Quarterly Finished Goods fell 41.06% year-over-year to $4.4 million in Q2 2023, while the trailing twelve-month figure through Jun 2023 was $4.4 million (down 41.06% YoY) and the FY2022 annual result came in at $6.6 million, up 100.86% from the prior year.
- Finished Goods was $4.4 million for Q2 2023 at Ginkgo Bioworks Holdings, down from $5.3 million in the prior quarter.
- Across five years, Finished Goods topped out at $8.0 million in Q1 2022 and bottomed at $2.5 million in Q3 2021.
- A 4-year average of $5.1 million and a median of $5.3 million in 2023 frame the typical range for Finished Goods.
- Annual changes were most pronounced in 2022 — Finished Goods soared 120.66% — and 2023, when it slumped 41.06%.
- Ginkgo Bioworks Holdings' Finished Goods stood at $2.8 million in 2020, then climbed by 18.43% to $3.3 million in 2021, then surged by 100.86% to $6.6 million in 2022, then sank by 32.35% to $4.4 million in 2023.
- Business Quant data shows DNA's Finished Goods at $4.4 million in Q2 2023, $5.3 million in Q1 2023, and $6.6 million in Q4 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Ginkgo Bioworks Holdings | 517.16 Mn | 373.30 Mn | 16.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 4.44 Mn |
| Mar 31, 2023 | 5.30 Mn |
| Dec 31, 2022 | 6.56 Mn |
| Sep 30, 2022 | 5.59 Mn |
| Jun 30, 2022 | 7.52 Mn |
| Mar 31, 2022 | 7.98 Mn |
| Dec 31, 2021 | 3.26 Mn |
| Sep 30, 2021 | 2.53 Mn |
| Dec 31, 2020 | 2.76 Mn |